ITI-007: Phase Ib/II started

Intra-Cellular began the 2-part, double-blind, placebo-controlled Phase Ib/II ITI-007-200 trial to evaluate multiple ascending-doses of oral ITI-007 in about 52 healthy geriatric subjects and patients...